Taken together, our results show a potential explanation for the poor prognosis observed in a group of men with low ESR1 levels, high necrosis, and an acute inflammation profile, which could have important implications for several aspects of glioma research and clinical practice. Here, ESR1 is linked to central nervous system cancer.